Showing results (1-10 of 720) with videos related to
Sort By:
Pageof 72
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Developmental therapeutics for myelodysplastic syndromesAung Naing, Lubomir Sokol, Alan F ListInternational Journal of Hematology|December 7, 2007
Immunomodulatory therapy for myelodysplastic syndromesLubomir Sokol, Alan F ListPlos One|April 18, 2012
Erythropoietin receptor signaling is membrane raft dependentKathy L McGraw, Gwenny M Fuhler, Joseph O Johnson, et al.Cancer Research|July 5, 2012
HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1Gisela Caceres, Robert W Robey, Lubomir Sokol, et al.Expert Opinion on Investigational Drugs|March 9, 2016
An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin's lymphomaSusmitha Apuri, Lubomir SokolExpert Opinion on Investigational Drugs|August 18, 2018
The advances in therapy of blastic plasmacytoid dendritic cell neoplasmDaniel Kerr, Lubomir SokolCancer Management and Research|July 5, 2022
Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell NeoplasmYumeng Zhang, Lubomir SokolClinical Lymphoma, Myeloma & Leukemia|November 1, 2020
Extranodal NK/T Cell Lymphoma: Evidence-based Review of Safety and Toxicity of the Available RegimensHayder Saeed, Lubomir SokolCancers|May 13, 2026
Revisiting the Origins of Cutaneous T-Cell Lymphoma: A Progenitor-Based ModelYumeng Zhang, Lubomir SokolPageof 72